Agios Pharmaceuticals, Inc. (AGIO) vs Azenta, Inc. (AZTA)
A side-by-side comparison of Agios Pharmaceuticals, Inc. and Azenta, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AGIO
Agios Pharmaceuticals, Inc.
$31.74HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
AZTA
Azenta, Inc.
$39.99HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
Total return — AGIO vs AZTA
growth of $100 · dividends reinvested · last 10yAGIO -41.9% (-5.3%/yr)AZTA +234.8% (+12.8%/yr)AZTA compounded faster over this window
Log scale — wide-divergence pair
AGIO AZTA
AGIO vs AZTA: by the numbers
- •AGIO is the larger company ($1.90B vs $1.84B market cap).
- •Both run net losses; AZTA's is the smaller (-20.02% vs -418.24% net margin).
- •AZTA grew revenue faster over the past five years (4.82% vs 4.54% CAGR).
Metrics side by side
Valuation
| Metric | AGIO | AZTA |
|---|---|---|
| Forward P/E | N/A | 80.51 |
| P/S ratio | 19.27 | 3.00 |
| P/B ratio | 1.85 | 1.22 |
| EV / EBITDA | N/A | 49.87 |
| FCF yield | N/A | 0.54% |
Profitability
| Metric | AGIO | AZTA |
|---|---|---|
| Gross margin | 78.67% | 44.05% |
| Operating margin | -873.87% | -3.49% |
| Net margin | -418.24% | -20.02% |
| ROE | -40.09% | -8.14% |
| ROIC | -44.21% | -1.33% |
Growth (annualized)
| Metric | AGIO | AZTA |
|---|---|---|
| Revenue CAGR (5Y) | 4.54% | 4.82% |
| Total return CAGR (5Y) | -6.59% | -15.91% |
Frequently asked
- Which has grown faster, AGIO or AZTA?
- Over the past five years, AZTA grew revenue faster — AGIO at a 4.54% CAGR versus AZTA at 4.82%.
- How have AGIO and AZTA total returns compared?
- Over the past 10 years, AGIO delivered -5.39% and AZTA delivered 12.81% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.